Latanostad Comp

Latanoprost, the active ingredient in Latanostad Comp, is a prostaglandin analog presented as eye drops for ocular use. Together with timolol, a non‑selective beta‑blocker, the combination treats primary open‑angle glaucoma and ocular hypertension by lowering intra‑ocular pressure in adult patients.

GNH USA supplies Latanostad Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for ophthalmic treatments across Europe and other regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Latanostad Comp acts on ocular pressure regulation pathways to manage glaucoma‑related conditions.

Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. Ocular hypertension: lowers eye pressure to prevent progression to glaucoma. Secondary open‑angle glaucoma: helps control pressure when other causes are present.

Common Side Effects: - Eye irritation or burning sensation - Transient blurred vision after instillation - Redness of the conjunctiva - Increased eyelash growth or darkening - Dry eye sensation - Mild itching or foreign‑body feeling

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema) - Uveitis or iritis - Persistent eye pain or photophobia - Sudden loss of vision - Systemic bradycardia or hypotension - Bronchospasm in susceptible individuals

Before initiating therapy, assess baseline intra‑ocular pressure and ocular health. - Hypersensitivity: avoid if patient has known allergy to prostaglandin analogues or beta‑blockers. - Iris pigmentation: monitor for possible darkening of iris color. - Respiratory conditions: use with caution in asthma or COPD patients. - Cardiovascular status: evaluate for bradycardia or heart block before use. - Store at room temperature: keep in original container, protect from light and moisture, and discard after the indicated period once opened.

Major Interactions (Avoid): - Systemic beta‑blockers: may increase risk of bradycardia or hypotension. - Non‑selective beta‑blocker eye drops: additive ocular beta‑blockade effects.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may affect pupil size and intra‑ocular pressure. - Other prostaglandin analogues: concurrent use can increase ocular irritation. - CYP2D6 inhibitors: may modestly raise timolol plasma levels. - Sympathomimetic agents: could counteract timolol's ocular effects.